ATN 143: COMPARE has opened enrollment at three of its eight recruitment sites: Atlanta, Chicago, and Chapel Hill. Recruitment will open soon in Boston, the Bronx, Houston, Philadelphia, and Tampa.
We optimized and pilot-tested two distinct mobile apps, LYNX and MyChoices, using a similar study design and identical study outcomes. Now, ATN 143: COMPARE will will allow us to identify any efficacy differences in increasing HIV testing or increasing PrEP uptake between the two apps. If justified, we will combine the components of each app that have the greatest impact on behaviors into a final, composite app for dissemination.
This research study will enroll approximately 462 young men who have sex with men across eight iTech recruitment sites. For more information about ATN 143: COMPARE, click here.
ATN 160: TechStep has opened enrollment at two of its five recruitment sites: Boston and New York City. Recruitment will open soon in Houston, Los Angeles, and Philadelphia. TechStep is a two-condition, technology-based randomized controlled trial (RCT), with a stepped care approach, among high-risk HIV-negative trans feminine, trans masculine, and gender non-conforming (here after: trans*) youth for reducing sexual risk behaviors (e.g., condomless anal intercourse, engagement in sex work, sex while feeling the effects of alcohol or drugs) and increasing PrEP uptake.
TechStep will enroll For more information about 330 people across five recruitment sites. ATN 160: TechStep, click here.